Results 11 to 20 of about 91,122 (346)
Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings [PDF]
The first Lewy Body Dementia Association (LBDA) Research Centers of Excellence (RCOE) Investigator’s meeting was held on December 14, 2017, in New Orleans.
Bethany Peterson +44 more
doaj +5 more sources
The presence of Lewy bodies (LB) in autonomic structures of the central and peripheral nervous system in Parkinson's disease (PD) is well known and could explain clinical signs of pure autonomic failure (PAF) or dysphagia, frequently associated with the disorder.
Kövari, Enikö +3 more
openaire +4 more sources
The Alzheimer Variant of Lewy Body Disease: A Pathologically Confirmed Case-Control Study [PDF]
The objective of the study was to identify clinical features that distinguish patients with dementia with Lewy bodies (DLB), who were classified as Alzheimer's disease ( AD) patients, from patients with AD.
Robert Perneczky +7 more
openalex +4 more sources
Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease. [PDF]
Objective Lewy body disease (LBD) is a complex neurodegenerative disorder characterized by the accumulation of misfolded α‐synuclein in the brain. Neuroinflammation has long been implicated in LBD pathogenesis, and recent genetic studies in Parkinson's disease (a clinical manifestation of LBD) have shown consistent association with the human leukocyte ...
Gavrielatos M +34 more
europepmc +2 more sources
I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review [PDF]
Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, which have abnormal aggregations of α-synuclein in the nigral and extranigral areas, including in the heart.
Eun Joo Chung, Sang Jin Kim
doaj +1 more source
Clinicopathological Correlates of Lewy Body Disease: Fundamental Issues [PDF]
Lewy body pathology (LBP) is the pathological hallmark of Lewy body diseases, such as Parkinson’s disease and Lewy body dementia. Recent studies have shed new light on the role of LBP, the interactions of LBP with concomitant pathologies, and the ...
Tae-Beom Ahn
doaj +1 more source
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and ...
Gregory D. Scott +54 more
doaj +1 more source
Background People with young-onset dementia (YOD) can often struggle getting the right treatment. This is because of their frequently different characteristics and needs compared to people with late-onset dementia. The aim of this project was to assess a
Clarissa Giebel +5 more
doaj +1 more source
End of life care in UK care homes during the COVID-19 pandemic: a qualitative study
Purpose To report the experiences of End of Life (EoL) care in UK care homes during the COVID-19 pandemic. Methods UK care home staff and family carers of residents in care home took part in remote, semi-structured interviews from October to November ...
Kerry Hanna +8 more
doaj +1 more source
Lewy body disease or diseases with Lewy bodies?
The current nosological concept of α-synucleinopathies characterized by the presence of Lewy bodies (LBs) includes Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), and dementia with Lewy bodies (DLB), for which the term “Lewy body disease ...
Kateřina Menšíková +15 more
doaj +1 more source

